Eko is applying machine learning in the fight against heart disease. It's a platform of cardiac screening devices, care coordination software, and interpretive algorithms to enable better monitoring and management of cardiovascular diseases. The company's first FDA-cleared device, CORE, is a smart stethoscope and software used by clinicians at over 1,000 hospitals & health systems around the globe and was recognized as a “Best Invention of the Year†by TIME Magazine. Eko's latest device, DUO, is the first cardiac monitor to combine digital stethoscope and ECG technology with machine learning for in-clinic and at-home patient monitoring.